SEC Form 4 · accession 0001104659-15-054456
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stefan K.F. Schwabe
Officer — Executive Vice President R&D
Period of report
Jul 28, 2015
Accepted (ET)
Jul 29, 2015 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2015 | S | 650 | $21.21 | D | 1,700 | D | |
| Common Stock | Jul 28, 2015 | S | 1,700 | $21.20 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.